DAVID JORDEN - CEO/CFO, Director at Nuo Therapeutics, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
CEO/CFO, Director
Issuer Symbol
AURX on OTC
All Insider Reports
All Insider Reports

DAVID JORDEN - trading volume in the past year for Nuo Therapeutics, Inc.

Holdings reported by DAVID JORDEN for Nuo Therapeutics, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 2,046,374 $4,031,356 $1.97 01 Jan 2026 Direct
Option to purchase common stock 0 31 Dec 2018 Direct Common Stock

Transactions reported by DAVID JORDEN for Nuo Therapeutics, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.